COVID-19: The global clinical trial landscape in 2024
COVID-19, caused by the SARS-CoV-2 virus, has profoundly reshaped global healthcare since its emergence in December 2019. By 2024, the…
All articles by Nikki Thompson
Nikki Thompson
-
-
Transforming preventative care in the NHS
The latest webinar from EMIS, a leading healthcare technology provider, showcased its Pathway platform—a robust tool designed to improve the…
-
Pioneering ePRO and eCOA innovations for next-generation clinical trials
The pharmaceutical industry is undergoing a major transformation, as clinical trials become increasingly data heavy and digital-based. Traditional methods of…
-
How to optimize efficiencies at site-centric clinical trials
The global clinical trials landscape has transformed significantly over the past five years. The Covid-19 pandemic accelerated the rapid adoption…
-
Chronic Lymphocytic Leukaemia: the global clinical trials landscape in 2024
Chronic lymphocytic leukaemia is a slow-growing leukaemia characterised by the accumulation of dysfunctional B lymphocytes, primarily affecting older adults. Its…
-
Understanding ICH Guideline Q14
The latest ICH guideline, Q14, complements Q2(R2) for the validation of analytical procedures. Revision of Q2(R1) into Q2(R2) aligns its…
-
ePRO vs eCOA: Understanding the nuances in clinical trials
Two such tools – electronic patient-reported outcomes (ePRO) and electronic clinical outcomes assessments (eCOA) – are often mentioned together. However,…
-
Oncology in 2024: The clinical trial trends reshaping the role of CROs
Oncology is the most active area in clinical trials globally this year, as more resources than ever are being dedicated…
-
Why data management and decision-making go hand-in-hand in clinical research
The pharmaceutical industry is fuelled by data. Huge amounts of information are available from sources as diverse as patient health…
-
A preferred destination: what’s driving Asia Pacific’s growth as a clinical trial hotspot
Research from GlobalData shows that the Asia-Pacific (APAC) region was the largest contributor to the global clinical trial landscape from…